Lamictal vs Latuda

Listen to the article instead of reading through it.


For patients with bipolar disorder or schizophrenia, certain medications that modify the levels of neurotransmitters in the brain can help manage their mood swings and other symptoms. Lamictal and Latuda are two such drugs frequently prescribed for these conditions. Both have significant impacts on various neurotransmitters within the brain, contributing to their stabilizing effects on mood.

Lamictal is an anticonvulsant medication also known as a mood stabilizer. It functions by decreasing excessive electrical activity in the brain which can lead to severe changes in mood and behavior among patients with bipolar disorder.

Latuda, on the other hand, is classified as an atypical antipsychotic drug primarily used for treating schizophrenia and depressive episodes associated with bipolar disorder. Its primary mechanism involves blocking receptors for dopamine and serotonin (two key neurotransmitters) in the brain. The choice between these two depends largely upon individual patient needs, tolerability, doctor's recommendation based on symptomatology amongst other factors.

What is Lamictal?

Lamotrigine (the generic name for Lamictal) is an anticonvulsant or antiepileptic drug, which was first approved by the FDA in 1994. It has since been a significant advancement from the earlier class of mood stabilizers and anti-seizure medications. Lamictal functions by decreasing abnormal electrical activity in the brain, thereby managing seizures and improving mood swings associated with bipolar disorder. Unlike other drugs targeting these conditions, Lamictal does not majorly affect serotonin or dopamine but instead focuses on glutamate inhibition.

On the other hand, Lurasidone (the generic name for Latuda) is an atypical antipsychotic that was approved by the FDA in 2010. Primarily used to treat schizophrenia and depression associated with bipolar disorder, it works differently than Lamictal as it targets both dopamine and serotonin receptors in the brain to restore their balance. The selective nature of Latuda results in fewer side effects compared to older generation antipsychotics that have more potent effects on various neurotransmitters.

What conditions is Lamictal approved to treat?

Lamictal is approved for the treatment of different mental health disorders:

  • Bipolar disorder, specifically used to delay mood episodes in people with bipolar disorder (manic depression) who have been treated with mood stabilizers
  • Epilepsy, either alone or in combination with other medications, including seizures associated with Lennox-Gastaut syndrome
  • Maintenance therapy for adults and pediatric patients aged 2 years and older suffering from epilepsy

How does Lamictal help with these illnesses?

Lamictal, known generically as lamotrigine, is a medication used primarily for treating epilepsy and bipolar disorder. It works by stabilizing electrical activity within the brain to control seizures and help regulate mood swings. This is thought to be achieved through decreasing the release of glutamate in the brain - an excitatory neurotransmitter that can over-stimulate neurons if not properly regulated.

On the other hand, Latuda or lurasidone is an atypical antipsychotic mainly prescribed for schizophrenia and bipolar depression. It functions by blocking certain receptors in the brain such as dopamine D2 receptors and serotonin 5-HT2A receptors. By doing so, it reduces abnormal excitement in the brain which helps stabilize mood disorders.

Both drugs play crucial roles in helping patients manage their conditions but work on different chemical messengers within our nervous system – Lamictal focuses on reducing excessive glutamate while Latuda primarily blocks overactive dopamine and serotonin signaling.

What is Latuda?

Latuda, the brand name for lurasidone, is an atypical antipsychotic that acts by antagonizing dopamine D2 receptors and serotonin 5-HT2A receptors in the brain. Its mechanism of action also involves partial agonist activity at serotonin 5-HT1A receptors. It was first approved by the FDA in 2010. Since Latuda is not a mood stabilizer like Lamictal (lamotrigine), it does not inhibit sodium channels or T-type calcium channels. This difference means its side effect profile varies from that of mood stabilizers; particularly, it can cause less skin rash which is commonly associated with Lamictal but has more potential to cause movement disorders and weight gain. The effects on dopamine and serotonin can be beneficial for the treatment of bipolar depression and schizophrenia, especially in patients who do not respond well to typical mood-stabilizing drugs such as Lamictal.

What conditions is Latuda approved to treat?

Latuda is an antipsychotic medication that has been approved by the FDA for treating:

  • Schizophrenia in adults and adolescents aged 13-17 years
  • Bipolar depression in adults as a standalone treatment and as part of a treatment plan with lithium or valproate.

How does Latuda help with these illnesses?

Dopamine is a neurotransmitter that plays several important roles in the brain and body, affecting mood regulation, memory function, voluntary movement, and reward response. In relation to mental health disorders such as bipolar disorder or schizophrenia, an imbalance of dopamine levels can contribute significantly to symptoms. Latuda works by rebalancing dopamine (and serotonin) within the brain which helps to alleviate some of these symptoms and improve quality of life for patients with these conditions. Its selective action on specific subtypes of receptors allows it to exert therapeutic effects while minimizing unwanted side effects often associated with other antipsychotics. Unlike Lamictal which primarily functions as a mood stabilizer through inhibition of voltage-sensitive sodium channels in neurons, Latuda may be more beneficial for those who also suffer from psychotic features due its additional antipsychotic properties. Therefore, it might be prescribed when a patient does not respond well to typical mood stabilizers like Lamictal or could be combined with them for enhanced efficacy.

How effective are both Lamictal and Latuda?

Both lamotrigine (Lamictal) and lurasidone (Latuda) have proven effectiveness in managing bipolar disorder, although they were approved by the FDA several years apart. Since they act on different neurotransmitters and receptors, their indications vary. Lamotrigine was directly studied in a double-blind clinical trial in 2000; it exhibited efficacy in delaying time to treatment for any mood episode during the maintenance phase of bipolar I disorder. Similarly, a 2013 study showed that lurasidone effectively managed depressive symptoms associated with bipolar disorder.

A 2016 review of meta-analysis reports demonstrated that lamotrigine is efficient at preventing or delaying depressive episodes more than manic episodes from the first few weeks of treatment. Its side effects profile is generally well-tolerated with rare but serious skin reactions being one notable exception if not monitored correctly. It has become an important drug used as mood stabilizer for long-term management of bipolar I disorder.

On the other hand, a 2017 review indicated that lurasidone seems to be more effective than placebo while treating depressive episodes related to both unipolar and bipolar depression without inducing mania. However, it's usually considered as second-line option after lithium or valproate due to its relatively recent introduction into psychiatric medication field compared to others like lithium or antipsychotics such as olanzapine or quetiapine which have been longer researched. Significant research on its use involves co-prescribing alongside lithium or valproate so data confirming its standalone efficiency needs further validation through rigorous studies. Nonetheless, due to its unique pharmacology - serotonin-dopamine activity modulation – Latuda may serve as an optimal choice for patients who did not respond well to first-line treatments or are prone to experiencing weight gain associated with many other options available currently.

abstract image of a researcher studying a bottle of drug.

At what dose is Lamictal typically prescribed?

Oral dosages of Lamictal for the treatment of epilepsy start at 25 mg/day and can be gradually increased by 25-50 mg every one to two weeks. The typical maintenance dose ranges from 100–200 mg/day with a maximum dosage of 400mg/day. For bipolar disorder, adults may start on a dosage plan that begins with 25 mg taken once daily which is incrementally increased over several weeks up to a maintenance dose typically between 100 -200mg per day.

Latuda, used in the treatment of schizophrenia and bipolar depression in adults and adolescents (10-17 years), has an initial dosage set at approximately 40 mg/day orally, although this may vary depending on the individual's circumstances. If needed, after clinical assessment, it can be titrated upwards by increments of no more than 20-40mg/week; however, doses above a total of 120mg/day have not been shown to provide additional benefit but could pose extra risk.

As always consult your doctor before beginning any new medication regime.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

At what dose is Latuda typically prescribed?

Latuda treatment is typically initiated at a dosage of 20 mg/day. The dose can then be progressively increased up to 120 mg/day, taken once daily with food (at least 350 calories). Dose adjustments should take place gradually, usually in increments or decrements of 20-40 mg per day. Monitoring for response to therapy and side effects is recommended during this period. If there's no significant improvement observed after a few weeks on the maximum dosage, the patient might need to consult their healthcare provider for alternative options or additional treatments.

What are the most common side effects for Lamictal?

Common side effects of Lamictal and Latuda can include:

  • Dizziness, headache, somnolence (sleepiness/drowsiness)
  • Unintentional trembling or shaking
  • Nausea, vomiting and diarrhea
  • Changes in weight and appetite
  • Difficulty sleeping (insomnia)
  • Restlessness or feeling jittery
  • Dry mouth, increased salivation
  • Rash, itching or skin discoloration
  • Muscle stiffness or twitching
  • Sweating excessively Note that both medications may also have serious side effects including suicidal thoughts. Always consult your healthcare provider for any concerns about these drugs' potential side effects.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Lamictal?

While both Lamictal and Latuda are used to manage bipolar disorder, they can come with some potential side effects.

For those taking Lamictal, it's important to monitor your mental health as there may be an increased risk of suicidal thoughts or behaviors. Also watch out for signs of severe skin reactions such as hives, difficulty breathing, swelling in the face or throat, and a rash that might include blistering and peeling. Vision problems like blurriness or tunnel vision are also possible side effects.

On the other hand, Latuda may cause similar psychiatric symptoms including suicidal thoughts or tendencies especially among younger users. Some people have experienced serious allergic reactions marked by hives; difficulty breathing; swelling of face, lips, tongue or throat. Unusual changes in mood or behavior should be reported promptly to healthcare professionals.

Both medications can affect heart rhythms causing fast/pounding heartbeats which could make you feel dizzy enough to pass out. Low sodium levels - indicated by headache, confusion slurred speech etc., stiffness in muscles accompanied by high fever (which might indicate a nervous system reaction), hallucinations indicative of serotonin syndrome - these are all rare but potentially serious symptoms associated with either medication that warrant immediate medical attention.

What are the most common side effects for Latuda?

Latuda, also known as lurasidone, may cause a range of side effects including:

  • Dry mouth or increased salivation
  • Nausea, vomiting, stomach upset, and loss of appetite
  • Sleep disturbances such as insomnia or excessive sleepiness
  • Restlessness and the feeling of needing to move constantly (akathisia)
  • Dizziness upon standing (orthostatic hypotension)
  • Slow heart rate
  • Weight gain rather than weight loss
  • Muscle stiffness and pain.

Please note that some patients may experience more serious side effects such as confusion or agitation. Always consult your health care provider if you notice any new or worsening symptoms while taking this medication.

Are there any potential serious side effects for Latuda?

While Latuda is generally well-tolerated, it can cause serious side effects in some circumstances. These might include:

  • Allergic reactions, such as skin rash, itching or hives; swelling of the face, lips or tongue
  • Unusual thoughts or behaviors including suicidal ideation
  • Seizures
  • Confusion and changes in mood
  • Vision disturbances such as blurred vision or seeing halos around lights
  • Rapid heartbeat
  • Symptoms of neuroleptic malignant syndrome like fever; stiff muscles; confusion; abnormal thinking; fast or irregular heartbeat and sweating.

If you experience any of these symptoms while taking Latuda, seek medical attention immediately. Your healthcare provider may need to adjust your dose or switch you to a different medication.

Contraindications for Lamictal and Latuda?

Both Lamictal and Latuda, along with most antipsychotic and mood stabilizing medications, may worsen symptoms of depression in certain individuals. If you notice your condition deteriorating or an increase in suicidal ideation or behavior while taking either of these medications, please seek immediate medical attention.

Neither Lamictal nor Latuda should be taken if you are using, or have recently discontinued the use of first-generation antipsychotics like haloperidol. Similarly to monoamine oxidase inhibitors (MAOIs) with antidepressants, there is a need for a washout period before transitioning from one class of medication to another to prevent dangerous drug interactions. Always inform your healthcare provider about all other medications that you are currently taking; first-generation antipsychotics will require appropriate time to clear from your system before initiating treatment with Lamictal or Latuda.

How much do Lamictal and Latuda cost?

For the brand name versions of these drugs:

  • The price of 60 tablets of Lamictal (100 mg) averages around $1200, which works out to $20–40/day, depending on your dose.
  • The price of 30 tablets of Latuda (40 mg) is about $1300, working out to approximately $43/day.

Thus, if you are in the higher dosage range for Lamictal (i.e., 300 mg/day or higher), then brand-name Latuda becomes more expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which of these drugs is right for you.

As for the generic versions:

  • Lamotrigine (generic version of Lamictal), costs can be significantly lower. Packs with varying quantities ranging from 30 up to even 500 tablets are available and costs can start from as low as $7 up to roughly $200 depending on quantity and daily dosage. This could mean an approximate cost between less than a dollar up to about four dollars per day based on typical dosages.

  • Lurasidone Hydrochloride (Generic form of Latuda), prices also vary but still lean towards being pricier than lamotrigine. A pack containing about 30 capsules may cost anywhere between roughly $80-$250 equating to an estimated daily expense ranging from around three dollars up until eight dollars depending on specific dosage instructions.

Popularity of Lamictal and Latuda

Lamotrigine, available in generic form and under the brand name Lamictal, is a mood stabilizer that has been prescribed to an estimated 3.8 million people in the U.S. in 2020. It accounted for roughly 16% of prescriptions for bipolar disorder medications. Despite being classified as an antiepileptic drug (AED), it's widely used off-label for treating bipolar disorder, particularly for preventing depressive episodes.

Lurasidone, marketed under the brand name Latuda, was prescribed to approximately 1 million people in the USA in 2020. In terms of prescriptions within atypical antipsychotics — its broad class — lurasidone accounts for nearly 6%. This medication emerged on market more recently than lamotrigine and has been gaining recognition since its approval by FDA in October 2010.

In conclusion, both drugs have shown efficacy against different aspects of bipolar disorder: lamotrigine mainly targets depression while lurasidone primarily addresses manic symptoms.


Both Lamictal (lamotrigine) and Latuda (lurasidone) have well-established use in the management of bipolar disorder, supported by numerous clinical studies indicating their effectiveness over placebo. Both drugs may be used together under careful supervision by a physician due to potential interactions between them. With distinct mechanisms of action - Lamictal primarily as a mood stabilizer that prevents episodes of depression in bipolar disorder while Latuda is an atypical antipsychotic with additional antidepressant properties - they tend to be prescribed for specific needs within the spectrum of bipolar disorder.

Lamictal is often considered first-line therapy for preventing depressive episodes in bipolar disorder, whereas Latuda might typically be used as an adjunctive treatment with other mood stabilizers or antipsychotics, or when there's need to control both manic and depressive symptoms simultaneously.

Generic versions are available for both medications which can mean significant cost savings especially if patients must pay out-of-pocket. It is important to note that upon initiating either drug, effects could take some time before becoming noticeable.

The side effect profiles do differ; while generally well-tolerated, each has its unique set of potential side effects: weight gain and metabolic changes are more common with Latuda than with Lamictal. As always when starting these treatments, it's crucial for patients to closely monitor any change in moods or behaviors and seek immediate medical attention should symptoms worsen or suicidal thoughts occur.